medroxyprogesterone has been researched along with Genetic Predisposition in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bray, PF; Herrington, DM; Howard, TD; Sane, DC; Vittinghoff, E | 1 |
Bilgen, T; Cetin, Z; Keser, I; Luleci, G; Simsek, M; Taskin, O | 1 |
1 trial(s) available for medroxyprogesterone and Genetic Predisposition
Article | Year |
---|---|
Effect of genetic variations in platelet glycoproteins Ibalpha and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy.
Topics: Aged; Alleles; Coronary Disease; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Female; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Humans; Medroxyprogesterone; Membrane Glycoproteins; Membrane Proteins; Mutation; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoproteins; Polymorphism, Genetic; Postmenopause; Risk Factors; Time Factors; Treatment Outcome | 2007 |
1 other study(ies) available for medroxyprogesterone and Genetic Predisposition
Article | Year |
---|---|
Effects of hormone replacement therapy on bone mineral density in Turkish patients with or without COL1A1 Sp1 binding site polymorphism.
Topics: Absorptiometry, Photon; Bone Density; Case-Control Studies; Collagen Type I; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Genetic Predisposition to Disease; Humans; Medroxyprogesterone; Middle Aged; Osteoporosis, Postmenopausal; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Sp1 Transcription Factor; Turkey; White People | 2008 |